Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gach

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Plos Pathogens|December 28, 2017
Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosisJohannes S Gach, Margaux Bouzin, Marcus P Wong, et al.
The Journal of Infectious Diseases|May 23, 2014
Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challengeSandeep Gupta, Poonam Pegu, David J Venzon, et al.
Plos Pathogens|August 12, 2010
A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individualsLaura M Walker, Melissa D Simek, Frances Priddy, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interfaceLikai Song, Zhen-Yu J Sun, Kate E Coleman, et al.
Plos One|January 24, 2014
HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional studyJohannes S Gach, Chad J Achenbach, Veronika Chromikova, et al.
Ebiomedicine|December 3, 2015
HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humansKatherine L Williams, Valerie Cortez, Adam S Dingens, et al.
Journal of Virology|June 12, 2009
A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodiesRobert Pejchal, Johannes S Gach, Florence M Brunel, et al.
Plant Biotechnology Journal|August 9, 2023
In planta expression of active bacterial GDP-6-deoxy-d-lyxo-4-hexulose reductase for glycan modulationBenjamin Kogelmann, Roman Palt, Daniel Maresch, et al.
Plos One|August 31, 2013
A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1Johannes S Gach, Heribert Quendler, Tommy Tong, et al.
Biotechnology Journal|October 7, 2023
A genome-edited N. benthamiana line for industrial-scale production of recombinant glycoproteins with targeted N-glycosylationBenjamin Kogelmann, Stanislav Melnik, Michaela Bogner, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Plos Pathogens|December 28, 2017
Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosisJohannes S Gach, Margaux Bouzin, Marcus P Wong, et al.
The Journal of Infectious Diseases|May 23, 2014
Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challengeSandeep Gupta, Poonam Pegu, David J Venzon, et al.
Plos Pathogens|August 12, 2010
A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individualsLaura M Walker, Melissa D Simek, Frances Priddy, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interfaceLikai Song, Zhen-Yu J Sun, Kate E Coleman, et al.
Plos One|January 24, 2014
HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional studyJohannes S Gach, Chad J Achenbach, Veronika Chromikova, et al.
Ebiomedicine|December 3, 2015
HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humansKatherine L Williams, Valerie Cortez, Adam S Dingens, et al.
Journal of Virology|June 12, 2009
A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodiesRobert Pejchal, Johannes S Gach, Florence M Brunel, et al.
Plant Biotechnology Journal|August 9, 2023
In planta expression of active bacterial GDP-6-deoxy-d-lyxo-4-hexulose reductase for glycan modulationBenjamin Kogelmann, Roman Palt, Daniel Maresch, et al.
Plos One|August 31, 2013
A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1Johannes S Gach, Heribert Quendler, Tommy Tong, et al.
Biotechnology Journal|October 7, 2023
A genome-edited N. benthamiana line for industrial-scale production of recombinant glycoproteins with targeted N-glycosylationBenjamin Kogelmann, Stanislav Melnik, Michaela Bogner, et al.
Pageof 5